期刊文献+

糖尿病肾病危险因素临床分析 被引量:3

Identification of clinical risk factors of diabetic nephropathy
暂未订购
导出
摘要 目的探讨糖尿病肾病(DN)的危险因素,为预防DN的发生、发展提供理论指导。方法对98例2型糖尿病患者分组进行回顾性流行病学危险因素调查分析。结果DN组和非DN组性别差异无统计学意义,但肥胖、年龄、病程、血脂、血压、糖化血红蛋白、空腹血糖差异均有统计学意义。结论DN的危险因素与血压、血脂、血糖控制、年龄、肥胖、病程有关。 Objective To identify the clinical risk factors of diabetic nephropathy(DN) and precent diabetic nephropathy from occurrence and development. Methods The nvailable clinical data collected from 98 cases of type Ⅱ diabetes were reviewed and the epidemiological risk factors were retrospectively analyzed. Results No significant sex difference was displayed in both DN and non-DN groups. However,remarkable differences on fatness, age course of disease,blood pressure, blood lipid glycosylated hemoglobin and fasting plasma glucose were found between DN and non-DN groups. Conclusion The rsk factors of DN are related to blood pressure, blood lipid, plasma glucose, age,fatness and course of disease.
作者 徐可佳
出处 《检验医学与临床》 CAS 2009年第12期978-978,980,共2页 Laboratory Medicine and Clinic
关键词 2型糖尿病 糖尿病肾病 危险因素 type 2 diabetes diabetic nephropathy risk factor
  • 相关文献

参考文献7

二级参考文献21

  • 1胡俊斌,魏文宁,丁桂芝,袁莉,刘仲萍.糖尿病患者凝血与纤溶状态初探[J].中华内分泌代谢杂志,1996,12(2):118-119. 被引量:32
  • 2陈清棠 主编.临床神经病学[M].北京:北京科学技术出版社,2002.178.
  • 3Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach[J] . Am J Kidney Dis, 2000, 36:646 - 661.
  • 4American Diabetes Association. Treatment of hypertension in adults with diabetes[ J ]. Diabetes Care, 2003, 26 : S80 -S82.
  • 5Ravid M, Brosh D, Levi Z, et al. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminurie patients with type 2 diabetes mellitus. A randomized, controlled trial[J]. Ann Intern Med, 1998, 128:982-988.
  • 6Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria[J]. BMJ, 1991,302:210 - 216.
  • 7Marre M, Chatellier G, LeBlanc Ⅱ, et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria[J]. Br Med J , 1998, 297:1092 - 1095.
  • 8Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitas: results of the HOPE study and MICRO-HOPE substudy[J]. Lancet, 2000, 355:253- 259.
  • 9Parring HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2001, 345:870 - 878.
  • 10Lewis E J, Hunsicker LG, Bain RP, et al. The effect of angiotesin-converting enzyme inhibition on diabetic nephropathy[J].N Engl J Med, 1993, 329:1456 - 1462.

共引文献591

同被引文献26

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部